Latest Breaking News On - Memory disorders division - Page 2 : comparemela.com

PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment (MCI) and Early-stage Alzheimer s Disease Patients

PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment (MCI) and Early-stage Alzheimer s Disease Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesVik chandraMarwan sabbaghRodney robertsUmethod healthMemory disorders division at barrow neurological instituteMemory disorders divisionBarrow neurological institute

PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment (MCI) and Early-stage Alzheimer s Disease Patients

/PRNewswire/ uMETHOD Health, a health technology company specializing in precision medicine for complex diseases, announces a partnership with PathGroup,.

United statesVik chandraMarwan sabbaghRodney robertsUmethod healthMemory disorders division at barrow neurological instituteMemory disorders divisionBarrow neurological institute

Synaptogenix (SNPX) Announces Changes to Scientific Advisory Board

Synaptogenix (SNPX) Announces Changes to Scientific Advisory Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel alkonMarwan sabbaghRobert howardGeorge perryAlan tuchmanPaul colemanUniversity of texas at san antonioOffice of alzheimer diseaseBarrow neurological instituteUniversity of rochester school medicineBrain healthNeuroscience neuropsychology of aging programNational institution on agingCampaign to prevent alzheimer diseaseNational alzheimer association

Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for.

United statesDaniel alkonRobert weinsteinMarwan sabbaghRobert howardGeorge perryAlan tuchmanPaul colemanUniversity of texas at san antonioOffice of alzheimer diseaseBarrow neurological instituteUniversity of rochester school medicineBrain healthNeuroscience neuropsychology of aging programNational institution on agingCampaign to prevent alzheimer disease

Dr Marwan Sabbagh Joins the Cognoptix Scientific Advisory Board

/PRNewswire/ Cognoptix, a groundbreaking diagnostic company for the early-stage detection of Alzheimer s disease (AD), announces today that Marwan Noel.

United statesPrnewswire cognoptixWyatt gordonMarwan sabbaghMarwan noel sabbaghBoston medical center neurologyBarrow neurological instituteMemory disorders divisionCleveland clinic lou ruvo centerBrain healthCognoptix incCognoptix scientific advisoryBoston medical centerAdvanced alzheimerEvidence based careGeriatric neurology